Article Details
Retrieved on: 2021-06-28 12:30:40
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Nasdaq: CRDF), a clinical-stage biotechnology company developing onvansertib to treat cancers with the greatest medical needs for new treatment ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here